High-Throughput Genomics and Bioinformatic Analysis (GBA)

高通量基因组学与生物信息学分析 共享资源 摘要 高通量基因组学和生物信息学分析共享资源（GBA）致力于支持 亨斯迈癌症研究所（HCI）的基因组实验和生物信息学分析需求。 GBA成立于1997年，由两个密切相关的部门组成，基因组学部门，由布赖恩达利领导， 生物信息学分析部分，由大卫尼克斯博士领导。两个部门都提供基因组 通过实验和分析过程指导癌症中心成员的专业人员， 不同的协议，使国家的最先进的研究，并不断审查和纳入新的 技术的利益HCI的研究计划。GBA的目标是：1）提供最先进的 基因组技术，服务和专业知识，2）支持科学研究的目标， 癌症中心通过使获得具有成本效益，先进的基因组方法， 研究，包括团队科学赠款。癌症中心内的GBA管理确保 资源的重点是解决癌症中心成员的基因组技术需求。 具体而言，GBA执行三个基本功能：1）招募和培养经验丰富的科学家， 生物信息学家和基因组技术人员支持癌症中心成员，2）提供多样化的产品组合 实验方案和分析工作流程，以实现基因组学的最新研究，以及3）评估， 实施和优化基因组测序和生物分析基础设施，以造福于研究人员 HCI。拥有同行评审资金的癌症中心成员占GBA用户的28%。用户受益于 通过癌症中心支持赠款，以高度补贴的成本提供卓越的资源质量 HCI支持自2014年以来，已有80多份出版物纳入了该资源支持的实验。 总而言之，GBA为癌症中心成员和犹他州大学提供全方位的服务设施 最先进的基因组学研究的研究人员，从实验设计，数据 生成和深入综合分析出版质量的数字和表格。GS提供评估 样品质量、Illumina测序文库的构建和鉴定以及Illumina测序。的 BAS进行数据分析服务，包括使用完善的 所有主要类别的下一代测序应用的分析协议。GBA也起到了关键作用 在HCI的翻译基因组学小组中发挥作用，该小组将研究人员和临床医生聚集在一起， 汇总患者数据集以改善临床护理。这些全面的服务使 来自不同学科的研究人员使用这些强大的工具来为他们的研究提供信息。

HIGH-THROUGHPUT GENOMICS AND BIOINFORMATIC ANALYSIS SHARED RESOURCE ABSTRACT The High-Throughput Genomics and Bioinformatic Analysis Shared Resource (GBA) is dedicated to supporting the genomic experimentation and bioinformatic analysis needs of Huntsman Cancer Institute (HCI). Established in 1997, GBA consists of two closely-aligned sections, the Genomics Section, led by Brian Dalley, PhD, and the Bioinformatic Analysis Section, led by David Nix, PhD. Both Sections provide teams of genomic professionals who guide Cancer Center members through the experimental and analytical processes, support diverse protocols enabling state-of-the-art research, and continuously review and incorporate novel technologies for the benefit of HCI’s Research Programs. GBA’s aims are: 1) to provide state-of-the-art genomic technologies, services, and expertise, and 2) to support the scientific research objectives of the Cancer Center by enabling access to cost-effective, sophisticated genomic approaches for high-impact research, including team science grants. Management of GBA within the Cancer Center ensures that the Resource is focused on addressing the genomic technology needs of Cancer Center members. Specifically, GBA performs three essential functions: 1) recruit and train highly experienced scientists, bioinformaticians, and genomic technicians to support Cancer Center members, 2) provide a diverse portfolio of experimental protocols and analysis workflows to enable the latest research in genomics, and 3) evaluate, implement, and optimize genomic sequencing and bioanalytic infrastructure for the benefit of researchers at HCI. Cancer Center members with peer-reviewed funding comprise 28% of GBA users. Users benefit from the exceptional quality of the Resource at a highly subsidized cost, enabled through Cancer Center Support Grant and HCI support. Since 2014, over 80 publications have included experiments supported by the Resource. In summary, GBA provides a full-service facility to Cancer Center members and University of Utah investigators for state-of-the-art genomics research that spans the spectrum from experimental design, data generation, and in-depth integrated analysis to publication-quality figures and tables. The GS offers evaluation of sample quality, construction and qualification of Illumina sequencing libraries, and Illumina sequencing. The BAS conducts data analysis services that include processing raw data to primary results using well-developed analytic protocols for all of the major classes of next-generation sequencing applications. GBA also plays a key role in HCI’s translational genomics groups, which bring together investigators and clinicians who work with aggregated patient-derived datasets to improve clinical care. These comprehensive services enable investigators from diverse disciplines to use these powerful tools to inform their research.